Association between Pre-Existing Long-Term β-Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study
Abstract
Share and Cite
Ma, Y.; Ma, J.; Yang, J. Association between Pre-Existing Long-Term β-Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study. Medicina 2022, 58, 1843. https://doi.org/10.3390/medicina58121843
Ma Y, Ma J, Yang J. Association between Pre-Existing Long-Term β-Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study. Medicina. 2022; 58(12):1843. https://doi.org/10.3390/medicina58121843
Chicago/Turabian StyleMa, Ying, Jie Ma, and Jiong Yang. 2022. "Association between Pre-Existing Long-Term β-Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study" Medicina 58, no. 12: 1843. https://doi.org/10.3390/medicina58121843
APA StyleMa, Y., Ma, J., & Yang, J. (2022). Association between Pre-Existing Long-Term β-Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study. Medicina, 58(12), 1843. https://doi.org/10.3390/medicina58121843